Citius Oncology, Inc. (CTOR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.97M | -7.35M | -5.53M | 0 | 0 | 0 | 900.29K | -364.06K | -191.69K | -218.19K | -105.53K | -45.39K |
| Operating CF Margin % | -237.99% | -186.48% | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | - | - | -714.72% | 100% | 100% | 100% | 953.14% | - | - | - | - | - |
| Net Income | -26.61M | -5.53M | -5M | -5.37M | -7.74M | -6.66M | -22.92M | 252.46K | 489.83K | 1.03M | 157.94K | 380.81K |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | -230.81K | 264.24K | 272.58K | 267.26K | 261.01K | 264.24K | 576K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4.97M | 4.53M | 2.17M | 2.06M | 2.15M | 1.81M | 10.17M | -634.02K | -758.26K | -1.28M | -560.97K | -486.99K |
| Working Capital Changes | 17.9M | -6.61M | -2.98M | 3.04M | 5.32M | 4.59M | 13.08M | 17.5K | 76.74K | 28.66K | 297.5K | 60.79K |
| Change in Receivables | 2.96M | -4.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -24.79K | -352.65K | -3.81M | -1.91M | -914.68K | -6.11M | -2.13M | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.62M | -2.79M | 4.64M | 1.01M | 1.78M | 2.16M | 2.42M | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -660.94K | -4.4M | -5.79M | 0 | 0 | 0 | -29.06M | -22.55K | 24.74M | -653.38K | -640.4K | -63.7M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | 0% | 0% | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -660.94K | -4.4M | -5.79M | 0 | 0 | 0 | -5M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -49.67K | 15.13M | 15.28M | 0 | 0 | 0 | 28.19M | 353.65K | -24.55M | 875.08K | 411.18K | 64.02M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 3.8M | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -49.67K | 15.13M | 15.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 24.39M | 353.65K | -24.55M | 875.08K | 411.18K | -363.21K |
| Net Change in Cash | -4.66M | 3.37M | 3.92M | 0 | 0 | -32.63K | -32.63K | -585 | 585 | 6.22K | -343.57K | 0 |
| Free Cash Flow | -3.97M | -7.35M | -5.53M | 0 | 0 | 0 | 900.29K | -364.06K | -191.69K | -218.19K | -105.53K | -45.39K |
| FCF Margin % | -237.99% | -186.48% | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | - | - | -714.72% | 100% | 100% | 100% | 953.11% | - | - | - | - | - |
| FCF per Share | -0.04 | -0.08 | -0.07 | - | - | - | 0.01 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
| FCF Conversion (FCF/Net Income) | 0.15x | 1.33x | 1.11x | - | - | - | -0.13x | 0.08x | 0.04x | 0.05x | 0.02x | -0.12x |
| Interest Paid | 0 | 14.46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |